Topic Paragraphs
FDA Covid-19 Response
FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Apr 08
NS NY Distributor Inc Issues Voluntary Nationwide Recall of Premium OrgaZen 7000 and Ginseng Power 5000 Due to Presence of Undeclared Sildenafil and/or Tadalafil
Drugs
Apr 07
Glutenull Bakery Issues Allergy Alert on Undeclared Milk in Goji Berries and Chocolate Cookies
Food & Beverages
Apr 05
Yolo Studio Issues Voluntary Nationwide Recall of PremierZEN Extreme 3000, PremierZEN Black 5000, & Triple SupremeZEN Plus 3500 Due to the Presence of Undeclared Tadalafil
Drugs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Accelerating Medical Device Innovation with Regulatory Science Tools
Regulatory science tools can play a key role in accelerating patient access to innovative, safe, and effective medical devices.
FDA’s Ongoing Use of Inspectional Tools for Ensuring Access to Safe, Quality Food and Medical Products During the COVID-19 Pandemic
Over the past year, FDA’s approach to foreign and domestic inspections for food and medical products has been both risk-based and deliberate.
FDA’s Partnership with Mexico’s Regulators Strengthens Food Safety Protections
The FDA-Mexico Food Safety Partnership broadens and strengthens the scope of our existing partnership to include the safety of all human food regulated by FDA.
Recently Published Guidances
Apr 05
Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers Guidance for Industry
Drugs
Mar 30
Guidance for Industry: Enforcement Policy for Providing an Acceptable Unique Facility Identifier (UFI) for the 2020 Food Facility Registration Biennial Renewal Period
Food & Beverages
Mar 04
COVID-19 Container Closure System and Component Changes: Glass Vials and Stoppers Guidance for Industry
Biologics, Drugs